COVID-19 pandemic The Subject Expert Committee of Central Drugs Standard Control Organisation allows Serum Institute of India to conduct trials of the Novavax COVID-19 vaccine for children aged 7 to 11 years old. Serum Institute gets nod to start Covovax trials on children above 7 yrs © Business Standard Sources: Business Standard